Profile
James E.
Pennington is a Clinical Professor at The University of California, San Francisco, where he has been employed since 1986.
He also served as Senior VP-Research Development & Clinical Affairs at Alpha Therapeutic Corp.
from 1999 to 2001.
Pennington has also worked as an Interim Chief Medical Officer at Trius Therapeutics, Inc. and as a Professor at Harvard Medical School.
Pennington's education includes a doctorate from Oregon Health & Science University and an undergraduate degree from the University of Oregon.
Currently, he is also the Chief Medical Officer at First Wave Biopharma, Inc. until 2022.
James Pennington active positions
| Companies | Position | Start |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1986 |
Former positions of James Pennington
| Companies | Position | End |
|---|---|---|
| GRIDAI TECHNOLOGIES CORP. | Chief Tech/Sci/R&D Officer | 31/03/2022 |
| ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Chief Tech/Sci/R&D Officer | 01/03/2007 |
| INTERMUNE INC | Chief Tech/Sci/R&D Officer | 01/01/2004 |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Develops of plasma derived products | Chief Tech/Sci/R&D Officer | 01/01/2001 |
Training of James Pennington
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Shaman Pharmaceuticals, Inc.
Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drug products | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Develops of plasma derived products | Health Technology |
Oregon Health & Science University
Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
- Stock Market
- Insiders
- James Pennington
















